Team:British Columbia/Wetlabteam

From 2011.igem.org

(Difference between revisions)

Latest revision as of 02:01, 5 August 2011

Team: British Columbia - 2011.igem.org

Team Members

Gurpal Bisra: My contribution to our wet lab component was to alter a yeast cell to contain the mutant erg20-2 gene instead of the wild type erg20 gene. I am making yeast bio-bricks for the erg20 and erg20-2 genes. Additionally, I am assisting Samuel Wu to develop plasmids that contain the K6R-HMG2 and IDI1 genes.	Daisy Ji	British Columbia Team member 3.png Marianne	British Columbia Team member 4.png Vicki
British Columbia Team member 5.png Joe: I am a 4th year science student at UBC, studying microbiology and genetics.	British Columbia Team member 6.png Sam	British Columbia Team member 6.png Jacob

Graduate Advisors

Alina Chan: My main wet lab role is to train team members in the art of working with yeast. I also help with general troubleshooting and experimental design.

Rafael, the fat monkey: oooooooooaaaaahhhhh

@@ Line 2: / Line 2: @@
 ==Team Members==
 <center><gallery>
-Image:Gurpal.jpg|Gurpal Bisra: I am an engineering physicist student interested in bioengineering and biology in general. I have traveled to 14 countries so far and my thirst for adventure never ceases. In my spare time, I enjoy drawing, doing martial arts, making people laugh and playing badminton.
+Image:Gurpal.jpg|Gurpal Bisra: My contribution to our wet lab component was to alter a yeast cell to contain the mutant erg20-2 gene instead of the wild type erg20 gene. I am making yeast bio-bricks for the erg20 and erg20-2 genes. Additionally, I am assisting Samuel Wu to develop plasmids that contain the K6R-HMG2 and IDI1 genes.
-My contribution to our wet lab component was to alter a yeast cell to contain the mutant erg20-2 gene instead of the wild type erg20 gene. Erg20 produces ~25% GPP and ~75% FPP molecules in the mevalonate biochemical pathway. GPP is essential to our project because it is the molecule that combines with a synthase in order to yield a monoterpene; where as, FPP does not develop monoterpenes. Since our goal is to mass produce monoterpenes, this mutation is key for our project to be successful.
-Additionally, I am assisting Samuel Wu to develop plasmids that contain the K6R-HMG2 and IDI1 genes. Their function is to alter the mevalonate pathway to ultimately produce more GPP as well.
 Image:Daisy.jpg|Daisy Ji